Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Amal A.E.-A Sadon"'
Publikováno v:
Egyptian Journal of Chest Disease and Tuberculosis, Vol 69, Iss 3, Pp 549-559 (2020)
Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal disease, with a median survival of ∼2–5 years. The main target of treatment was to stabilize or reduce the rate of disease progression. Nintedanib and pirfenidone
Externí odkaz:
https://doaj.org/article/66e59a109cd84a32aff1e988f0c227cb
